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Myocardin-Related Transcription Factors A and B (MRTF-A and MRTF-B) are highly homologous proteins
that function as powerful coactivators of serum response factor (SRF), a ubiquitously expressed tran-
scription factor essential for cardiac development. The SRF/MRTF complex binds to CArG boxes found in
the control regions of genes that regulate cytoskeletal dynamics and muscle contraction, among other
processes. While SRF is required for heart development and function, the role of MRTFs in the developing
or adult heart has not been explored. Through cardiac-speciﬁc deletion of MRTF alleles in mice, we show
that either MRTF-A or MRTF-B is dispensable for cardiac development and function, whereas deletion of
both MRTF-A and MRTF-B causes a spectrum of structural and functional cardiac abnormalities. Defects
observed inMRTF-A/B null mice ranged from reduced cardiac contractility and adult onset heart failure to
neonatal lethality accompanied by sarcomere disarray. RNA-seq analysis on neonatal hearts identiﬁed
the most altered pathways in MRTF double knockout hearts as being involved in cytoskeletal organi-
zation. Together, these ﬁndings demonstrate redundant but essential roles of the MRTFs in maintenance
of cardiac structure and function and as indispensible links in cardiac cytoskeletal gene regulatory
networks.
& 2015 Elsevier Inc. All rights reserved.1. Introduction
Development of the heart and maintenance of cardiac function
require precise regulation of many genes involved in cardiac mor-
phogenesis, contractility, and energy homeostasis (Olson, 2006). Per-
turbations in cardiac gene regulation can result in congenital heart
defects, the most common human birth defect (Reller et al., 2008).
Members of the myocardin family of transcription factors act as
transcriptional co-activators for serum response factor (SRF), a
ubiquitously expressed MADS-box transcription factor, to potently
stimulate SRF-dependent gene expression (Wang et al., 2001,,
2002). SRF binds as a homodimer to CArG boxes (consensus se-
quence: [CC(A/T)6GG]) found in the control regions of many genes
that regulate actin dynamics and muscle contractility (Miano et al.,
2007; Treisman, 1987). Myocardin and Myocardin-Relatedr Biology, University of Texas
oulevard, Dallas, TX 75390,Transcription Factors A and B (MRTF-A/MAL/MKL1 and MRTF-B/
MKL2) are essential for SRF function and enhance SRF activity
(Olson and Nordheim, 2010). The MRTFs are thought to act in part
by relaying information about the state of actin polymerization
from the cytoplasm to the nucleus, mediated by RPEL domains
(Miralles et al., 2003; Vartiainen et al., 2007). In contrast, the
N-terminus of myocardin lacks the RPEL domains necessary to
mediate interaction with actin, suggesting that myocardin and the
MRTFs might have unique biological functions despite their strong
homology (Kuwahara et al., 2005; Olson and Nordheim,
2010; Wang et al., 2001). Consistent with this notion, while
myocardin is expressed speciﬁcally in cardiac and smooth muscle
cells (Wang et al., 2001), MRTF-A and MRTF-B are expressed in a
broad range of embryonic and adult tissues (Wang et al., 2002).
MRTFs are sequestered in the cytoplasm as a result of their in-
teraction with G-actin monomers. Upon stimulation by actin
polymerization, MRTFs are liberated from their interaction with
G-actin and subsequently translocate into the nucleus where they
act with SRF to activate genes involved in cytoskeletal dynamics
(Miralles et al., 2003; Pipes et al., 2006; Vartiainen et al., 2007).
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in embryonic lethality, indicating its essential role in heart de-
velopment (Miano et al., 2004; Niu et al., 2005). Similarly, condi-
tional deletion of SRF in the adult heart results in dilated cardio-
myopathy and lethality within 10 weeks of inactivation, conﬁrm-
ing a critical role for SRF in cardiac function (Parlakian et al., 2005).
Myocardin-null mice die during early embryogenesis due to a
failure in vascular smooth muscle development (Li et al., 2003)
while cardiac-speciﬁc loss of myocardin during early cardiac de-
velopment using a ﬂoxed Myocardin allele together with an
Nkx2.5-Cre transgene led to defects in cardiac growth and ma-
turation; this defect was mediated at least in part via inactivation
of Bmp10 (Huang et al., 2012). In contrast, cardiac-speciﬁc deletion
of myocardin with an αMHC-Cre transgene, which becomes active
slightly later in development, causes adult onset heart failure ac-
companied by sarcomere disruption, but no overt cardiac mor-
phological defects (Huang et al., 2009), though a fraction of these
animals succumbs to early postnatal lethality. In addition to its
role in postnatal cardiac function, myocardin is also essential for
vascular homeostasis; deletion of myocardin in smooth muscle
cells in adult animals led to lethality within 6 months, accom-
panied by defects in arterial structure and visceral smooth muscle
maintenance (Huang et al., 2015).
MRTF-A / mice are viable and display no cardiac abnormal-
ities (Li et al., 2006; Sun et al., 2006) while MRTF-B / mice die
during mid-gestation from defects in branchial arch neural crest
development and smooth muscle cell differentiation without overt
cardiac abnormalities (Li et al., 2005; Oh et al., 2005). Thus, it re-
mains unclear whether the MRTFs are essential for heart devel-
opment. In other contexts, however, including neural (Mokalled
et al., 2010), hematopoietic (Costello et al., 2015) and angiogenic
(Weinl et al., 2013) development, a redundant role for the MRTFs
has been demonstrated.
To explore the functions of MRTFs in heart development, we
generated mice lacking combinations of MRTF-A and MRTF-B al-
leles through cardiac-speciﬁc gene deletion. Here, we show that
cardiac deletion of MRTF-B in an MRTF-A null background results
in a range of cardiac defects from neonatal lethality with ab-
normalities in sarcomere organization to adult-onset heart failure.
We identify a broad collection of cardiac genes that are dysregu-
lated in response to MRTF depletion in the heart. Our ﬁndings
reveal a requirement for MRTF-A and MRTF-B in cardiac function
that reﬂects the essential roles of MRTFs in cardiac cytoskeletal
gene regulatory networks.2. Materials and methods
2.1. Mouse lines
The MRTF-A / mice and MRTF-Bﬂ/ﬂ conditional mice have
been previously described (Li et al., 2006; Mokalled et al., 2010).
MRTF-A / , MRTF-Bﬂ/ﬂ , and αMHC-Cre mice were crossed to
generate MRTF-A /; MRTF-Bﬂ/ﬂ ; αMHC-Cre animals, which we
refer to as MRTF cardiac double knockout (MRTFcdKO) mice. Lit-
termates were used as control animals. Controls were MRTF-A / ,
MRTF-Bf/f or MRTF-Aþ /;MRTF-Bf/f. All animal experiments were
approved by the UT Southwestern Institutional Animal Care and
Use Committee.
2.2. Histology and electron microscopy
Control and MRTFcdKO mice were sacriﬁced at the indicated
time points, hearts were ﬁxed in 4% paraformaldehyde for 48 h,
embedded in parafﬁn, and sectioned. Sections were stained with
hematoxylin and eosin (H&E) and Masson's trichrome usingstandard procedures. For transmission electron microscopy, heart
tissue was isolated and prepped according to standard protocols.
Electron microscopy protocols are described in detail in the Sup-
plementary Material and Methods.
2.3. Quantitative RT-PCR analysis
Total RNA was puriﬁed from tissues using TRIzol reagent ac-
cording to the manufacturer’s instructions (Invitrogen). For RT–
PCR, total RNA was used as a template for RT using random hex-
amer primers. qPCR was performed using primers located within
the deleted exons of the MRTF-A and MRTF-B genes.
2.4. RNA isolation and RNA-seq analysis
Hearts were harvested from P0 pups of both wild type and
MRTFcdKO mice and were immediately frozen in liquid nitrogen.
Heart tissues were resuspended in 1 ml of Trizol and homogenized
using 20 g needles. Following chloroform extraction, the super-
natant was mixed with equal volume of 75% ethanol and loaded
on RNeasy mini-columns (Qiagen). Total RNA was isolated ac-
cording to manufacturer’s instructions (Qiagen). RNA quality was
veriﬁed by the Agilent 2100 Bioanalyzer and RNA-seq was per-
formed using Illumina HiSeq 2500 by the Next-Generation Se-
quencing Core at the McDermott Center at UT Southwestern
Medical Center (GEO accession number GSE69726). Bioinformatics
analysis methods are described in Supplementary Materials and
Methods.
2.5. Transthoracic echocardiography
Cardiac function and heart dimensions were evaluated by
2-dimensional echocardiography on conscious 7–8 week-old mice
using a Visual SonicsVevo 2100 system equipped with a 35MHz
transducer. Analysis information is found in Supplementary Ma-
terials and Methods.
2.6. Statistical analysis
Results are expressed as mean 7 SEM. Unpaired 2-tailed Stu-
dent t-test with Welch correction was performed to determine
statistical signiﬁcance. P values of o0.05 were considered
signiﬁcant.3. Results
3.1. Generation of mice lacking MRTF-A and MRTF-B in the heart
Because MRTF-A / mice are viable and display no overt car-
diac abnormalities (Li et al., 2006), whereas MRTF-B/ mice die
embryonically from vascular defects (Oh et al., 2005), we ﬁrst in-
vestigated the potential role of MRTF-B in heart development by
cardiac-speciﬁc deletion of a conditional ﬂoxed MRTF-B allele
(Mokalled et al., 2010), using an αMHC-Cre transgene, which
mediates gene recombination and deletion in cardiomyocytes
(Agah et al., 1997). Mice with cardiac deletion of MRTF-B (MRTF-B
cKO mice) were viable and showed no abnormalities for up to a
year of age (data not shown). As neither MRTF-A nor MRTF-B is
individually required for heart function, we hypothesized that they
might possess partially redundant functions. To assess this, we
generated mice lacking both MRTF-A and MRTF-B in the heart by
breeding MRTF-BcKO mice to MRTF-A/ mice (Fig. S1A). We refer
to these mice as MRTF cardiac double knockout (cdKO) mice.
MRTFcdKO mice were born at approximately Mendelian ratios,
suggesting that MRTF activity is not required for early
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Fig. 1. MRTFcdKO mice display postnatal lethality. (A) Shown is the percent survival of control and MRTFcdKO mice (n¼20/genotype). More than 75% of MRTFcdKO mice died
within 2 weeks of birth while 25% of mice lacking 3 out of 4 MRTF alleles died between 2 and 4 weeks of age. (B) Whole mount and H&E-stained heart sections from
control and MRTFcdKO P0 mice are shown.MRTFcdKO hearts showed no obvious cardiac defects. Scale bar: 1 mm. (C) Masson’s trichrome staining revealed the presence of left
ventricular dilation and ﬁbrosis in MRTFcdKO hearts at both 10 days and 3 weeks after birth, indicative of cardiomyopathy and heart failure. Scale bar: 2 mm.
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MRTFcdKO mice died within the ﬁrst two weeks of birth with the
remaining 25% dying between 4 and 12 weeks of age (Fig. 1A),
indicating that MRTFs play a critical role in cardiac function.
To conﬁrm efﬁcient deletion of the MRTF genes, we performed
quantitative real-time PCR (qPCR) on isolated MRTFcdKO hearts at
postnatal day 0 (P0) using primers located within the deleted
exons of the MRTF-A and MRTF-B genes (Fig. S1B). We observed an
absence of MRTF-A expression while MRTF-B levels were reduced
by 50%, likely reﬂecting its residual expression in non-cardio-
myocyte cell populations in which the αMHC-Cre transgene is
inactive. Alternatively, it has been reported that deletion of
Gata4ﬂ/ﬂ alleles using the αMHC-Cre transgene only results in loss
of about 70% of the GATA4 protein by 8 weeks of age (Oka et al.,
2006), suggesting that part of the residual MRTF-B expression may
be due to incomplete takeout of the MRTF-Bﬂ/ﬂ alleles. While
MRTF-A / mice andMRTF-BcKO mice in a mixed background were
viable, 20% of MRTF-Aþ /;MRTF-BcKO and MRTF-A/;MRTF-B
þ / mice, which each retain one functional MRTF allele in the
heart, died between weeks 2 and 4 of age (Fig. 1A), with the re-
maining 75% surviving until at least 12 months. The premature
lethality in mice with only one functional MRTF allele indicates
that MRTF-A and MRTF-B act redundantly in the heart and that a
threshold of MRTF activity is required for normal cardiac function.3.2. Cardiac abnormalities resulting from MRTF deletion
Interestingly, at P0, MRTFcdKO hearts appeared normal both in
overall appearance and at a histological level by H&E staining
(Fig. 1B). However, MRTFcdKO animals that survived to 10 days of
age exhibited dilation of the left ventricle as well as ﬁbrosis, as
assessed by Masson’s trichrome stain, suggesting poor cardiac
function (Fig. 1C and Fig. S1C). While most MRTFcdKO mice died
within 2 weeks of birth, those that survived to 3 weeks of age
showed extreme cardiac dilation and regions of ﬁbrosis, together
indicative of heart failure (Fig. 1C and Fig. S1C). To characterize the
cardiac defects present in mice lacking three of the four MRTF al-
leles, we performed histological analysis of hearts by H&E staining;
this revealed a range of cellular and structural cardiac abnormal-
ities (Fig. 2A). Approximately 75% of MRTF-Aþ /;MRTF-BcKO hearts
at 3 weeks of age appeared normal and indistinguishable from
control hearts, whereas the other 25% were dilated with thin
ventricular walls. Similar results were obtained for MRTF-A /;
MRTF-Bþ / animals, suggesting a minimal level of MRTF activity is
required for proper cardiac function.
To assess cardiac function in MRTFcdKO animals, we performed
echocardiography at 7–8 weeks of age; these studies revealed a
slight reduction in fractional shortening in the hearts of adult
MRTF-Aþ /;MRTF-BcKO and MRTF-A /;MRTF-Bþ / mice (Fig. 2B),
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Fig. 2. MRTFcdKO animals show defects in cardiac function. (A) H&E staining of heart sections from control, MRTF-Aþ /;MRTF-BcKO, and MRTF-A/;MRTF-Bþ / mice at
3 weeks of age are shown at low and high magniﬁcation in the upper and lower panels, respectively. Scale bars: 2 mm for upper panels; 40 mm for lower panels. Ap-
proximately 25% of MRTF-Aþ /;MRTF-BcKO, and MRTF-A/;MRTF-Bþ / mice showed cardiac dilation and cardiomyocyte disorganization. (B) MRTF-Aþ /;MRTF-BcKO and
MRTF-A /;MRTF-Bþ / mice showed a slight reduction in fractional shortening (FS) compared to control animals at 7–8 weeks of age by echocardiography while surviving
MRTFcdKO animals showed an 50% reduction in FS (n¼4/genotype).
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few MRTFcdKO mice that survived to adulthood showed the most
severe cardiac dysfunction, with extreme ventricular dilation and
50% reduction in cardiac function compared to control hearts
(Fig. 2B and Fig. S1D), indicating severe deﬁcits in cardiac output.
3.3. MRTFcdKO hearts display sarcomere disarray
While we observed the most penetrant lethality of MRTFcdKO
mice shortly after birth, the hearts of these animals appeared
grossly normal and indistinguishable from control hearts at P0
(Fig. 1B). Given the known role of the MRTFs in relaying in-
formation about the state of the cytoskeleton to the nucleus (Olson
and Nordheim, 2010), we sought to examine sarcomere formation
in the ventricles of P0 hearts. Strikingly,MRTFcdKO hearts displayed
extensive regions of severely disrupted sarcomeres as observed by
electron microscopy (Fig. 3A). While control hearts displayed the
expected organized myoﬁbrils of actin and myosin ﬁlaments,
MRTFcdKO hearts showed areas of thickened and disorganized
Z-bands and an obvious decrease in the presence of M-bands.
Additionally, we observed that mitochondrial structure and
number were compromised in MRTFcdKO hearts at P0 (Fig. 3A).
While we observed varying degrees of sarcomere disruption in the
MRTFcdKO animals, all hearts examined showed extensive defects
in sarcomere formation, suggesting sarcomeric abnormalities as a
primary cause of the increased lethality. Similarly, electron mi-
croscopy on the left ventricle of a 7-week MRTFcdKO animal re-
vealed sarcomeric defects. While some regions of the cdKO heart
displayed the expected sarcomere arrangement and cytoskeletal
organization, other areas showed complete disarray, with minimal
M-bands and only a few disorganized Z-bands (Fig. 3B), explaining
the observed reduction in cardiac contractility by echocardio-
graphy (Fig. 2B). Together, these results indicate that MRTFcdKOhearts display defects in sarcomeric structure that impede cardiac
function.
3.4. RNA-seq analysis reveals changes in sarcomeric and cytoskele-
ton genes
To determine the genetic and molecular mechanisms underlying
the enhanced lethality in MRTFcdKO mice, we performed RNA-seq
analysis on hearts isolated at P0 and validated the results using RT-
qPCR (Fig. S3). By bioinformatics analysis, we identiﬁed 605 genes
with differential expression in MRTFcdKO hearts compared to wild
type; within this set, 317 were down-regulated while 288 showed an
increase in expression (Fig. 4A and Table S1). Using Ingenuity Path-
way Analysis (IPA), we identiﬁed multiple pathways that were sig-
niﬁcantly altered in MRTFcdKO hearts (Fig. 4B). The top 5 pathways
identiﬁed as dysregulated all related to cytoskeletal organization,
conﬁrming the essential role of the MRTFs in cytoskeleton main-
tenance and function (Olson and Nordheim, 2010). Sixteen out of 21
genes in these pathways were down-regulated (Fig. 4C and Table S2).
While we did observe that 5 genes related to the cytoskeleton were
upregulated in MRTFcdKO hearts, it remains to be elucidated if these
changes are compensatory alterations due to sarcomere disruption or
if these genes represent true MRTF targets genes in the heart. We
also utilized DAVID to identify enriched Gene Ontology (GO) terms
among the genes differentially regulated in MRTFcdKO hearts (Fig.
S2A). In addition to several metabolism-related categories, GO ana-
lysis identiﬁed 37 genes as implicated in cell death (Fig. S2B and
Table S3), suggesting a critical role for the MRTFs in cardiac cell
survival. Importantly, myocardin has also been identiﬁed as critical
for cardiomyocyte survival (Huang et al., 2009), suggesting the MRTF
family is essential for cardiomyocyte maintenance.
As MRTFs are thought to act primarily as transcriptional acti-
vators through their interaction with SRF (Olson and Nordheim,
Control cdKO
Control cdKO
Fig. 3. Defects in sarcomere arrangement in MRTFcdKO hearts. (A) Electron micrographs of control and MRTFcdKO hearts at P0 reveal severe sarcomere disarray with dis-
organized Z-bands (arrows) and absent M-bands (red arrowheads) as well as mitochondrial abnormalities (white arrowheads). Scale bars: 4 mm for the upper panels and
1 mm for the lower panels; n¼4/genotype. (B) Electron micrographs of control andMRTFcdKO left ventricle at 7 weeks of age showed regions of sarcomere disarray, as well as
regions that looked relatively normal. Scale bars: 2 mm for the upper panels and 1 mm for the lower panels.
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pression inMRTFcdKO hearts. DAVID analysis of the down-regulated
genes identiﬁed a variety of enriched GO terms related to muscle
and the cytoskeleton, including actomyosin structure organization,
myoﬁbril assembly, striated muscle development, and muscle thin
ﬁlament assembly, conﬁrming the critical role of MRTFs in muscle
function. In addition, GO identiﬁed other categories as signiﬁcantly
altered in MRTFcdKO hearts, including translation and DNA meta-
bolism, replication, and repair, suggesting the MRTFs could play a
role in these processes as well (Fig. 4D).
As the MRTFs are known to signal with SRF via binding of the
SRF-MRTF complex to CArG boxes, we performed a bioinformaticssearch for conserved CArG boxes associated with genes that were
differentially expressed as measured by RNA-seq. Of these differ-
entially expressed genes, we found that 212 (35%) had at least
one CArG box that was conserved (Table S4) and located within
5kb of the transcriptional start site (TSS), suggesting that MRTFs
exert at least part of their effects on cardiac development through
an interaction with SRF and the binding of CArG boxes. A recent
analysis of SRF binding sites in the genome of ﬁbroblasts sug-
gested that 70% of SRF binding sites were found within 2 kb of
the TSS (Esnault et al., 2014). However, some binding sites far from
the TSS were also reported, which raises the possibility that we are
underestimating the number of regulated genes that contain CArG
Fig. 4. Molecular analysis of MRTFcdKO hearts. (A) Heat map of the top 50 genes whose expression was altered in MRTFcdKO hearts at P0. (B) Pathway analysis of differentially
expressed genes in MRTFcdKO hearts revealed regulation of many pathways related to the cytoskeleton. (C) Heat map showing 16 genes related to actin and cytoskeletal
signaling have decreased levels of expression in MRTFcdKO hearts. (D) GO analysis identiﬁed multiple enriched terms related to genes down-regulated in MRTFcdKO hearts.
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fore, we compared the genes regulated by MRTFs in MRTFcdKO
hearts with known SRF binding sites, utilizing publicly available
ChIP-Seq data (Schlesinger et al., 2011). Of the 605 differentially
expressed genes in MRTFcdKO hearts, we identiﬁed 53 (8.7%) that
were also SRF binding sites in HL-1 cells (Table S5), suggesting that
they could be direct targets of MRTF-SRF regulation. Among these
genes were multiple regulators of the cytoskeleton and muscle
function including Actc1, Actb, Myl9, Tpm2, Cnn1, Cnn2, Actg1, and
Acta1. The multitude of cytoskeletal genes in this small subset of
regulated genes suggests that the defects in sarcomere formation
and cardiomyocyte function we observed are likely a result of di-
rect regulation of key SRF target genes by MRTF binding. Together,
our RNA-seq data conﬁrm that the MRTFs are critical regulators of
cardiac development and suggest that alterations in the cytoske-
leton are the predominant cause of the lethality in MRTFcdKO
animals.4. Discussion
The results of this study demonstrate that the MRTFs are re-
quired for cardiac development and function. Ablation of all four
MRTF alleles causes postnatal lethality with sarcomeric disarray
whereas deletion of three MRTF alleles results in dilated cardio-
myopathy and mild adult onset heart failure. The dysregulation of
genes controlled by SRF and the similarities between the pheno-
types of MRTF and SRF mutant mice (Miano et al., 2004; Niu et al.,
2005; Parlakian et al., 2005, 2004) point to MRTFs as criticalmediators of SRF activity in the heart in vivo.
Global SRF deletion in mice results in lethality at gastrulation
due to a gross failure in mesoderm formation, preventing analysis
of the role of SRF in cardiac development or function (Arsenian
et al., 1998). However, deletion of a conditional SRF allele in the
embryonic heart, using an αMHC-Cre transgene, results in cardiac
insufﬁciency and lethality by E12.5 (Niu et al., 2005), while dele-
tion of SRF in the adult heart yields dilated cardiomyopathy and
heart failure, indicating that SRF remains essential for adult cardiac
function (Parlakian et al., 2005). The abnormalities observed with
the MRTFcdKO mice phenocopy multiple aspects of the defects
observed with cardiac SRF deletion, including cardiac dilation and
sarcomere disarray, and support the conclusion that MRTFs are
obligatory regulators of SRF activity in the heart. However, unlike
mice in which SRF was deleted with αMHC-Cre, which die em-
bryonically by E12.5 (Niu et al., 2005), MRTFcdKO mice survive until
after birth, and occasionally into adulthood. We speculate that
myocardin, which is highly expressed in the embryonic heart,
partially compensates for the absence of MRTF-A and –B and al-
lows cardiac development to proceed beyond the point in which
cardiac deletion of SRF causes lethality. Generation of myocardin/
MRTF-A/B triple knockout animals will be required to test this
prediction.
The phenotype of MRTFcdKO mice is reminiscent of animals in
which αMHC-Cre was used to delete a ﬂoxed Myocardin allele.
These mice showed enhanced lethality, beginning shortly after
birth, with all mice dying before 1 year of age, accompanied by
cardiac dilation, decreased heart function, and sarcomere disarray
(Huang et al., 2009). The similarity between the phenotypes of
M.H. Mokalled et al. / Developmental Biology 406 (2015) 109–116 115mice in which MRTF-A and MRTF-B or myocardin were deleted
with αMHC-Cre suggests that they may play similar roles in car-
diac development and function. In addition to their cardiomyo-
cyte-speciﬁc functions, MRTFs have been shown to play other roles
in the heart, including activation of the cardiac ﬁbrotic gene pro-
gram (Small et al., 2010) and coronary vascular development and
maturation (Trembley et al., 2015), while functions for myocardin
and MRTFs in smooth muscle differentiation and development
have been extensively investigated (Li et al., 2006; 2003; Oh et al.,
2005; Wang et al., 2004), indicating that MRTFs are critical reg-
ulators of multiple aspects of cardiac development and function.
Consistent with the role of the MRTF/SRF pathway as a critical
regulator of heart development and homeostasis, our RNA-seq ana-
lysis on P0 MRTFcdKO hearts conﬁrmed that the MRTFs play an es-
sential role in cardiac function, largely through regulation of the cy-
toskeleton and associated proteins. Interestingly, while the MRTF/SRF
complex is considered a transcriptional activator, we observed that
nearly half of the regulated genes in MRTFcdKO hearts showed in-
creased expression. Whether up-regulation of these genes reﬂects
indirect effects of the loss of the MRTFs in the heart or whether the
MRTFs have some other function outside their role as SRF coactivators
remains to be elucidated. One notable observation in our RNA-seq
analysis was that several of the upregulated genes in MRTFcdKO hearts
are also predicted to be sites of SRF binding (Table S5). It is unclear if
these are valid SRF target genes. Additionally, it is conceivable that the
MRTFs and/or SRF could have other binding partners that remain to be
discovered. Consistent with this possibility, several instances of the
MRTFs acting partially independent of SRF to alter gene expression
have been described (Asparuhova et al., 2011; Hayashi et al., 2015),
suggesting the MRTFs could have SRF-independent roles in the heart;
future work will explore this possibility further. However, the sig-
niﬁcant down-regulation of known SRF target genes that encode es-
sential regulators of cytoskeleton maintenance and function in
MRTFcdKO hearts underscores the critical role of the MRTFs as SRF
coactivators and suggests that regulation of SRF activity is the primary
cause of the lethality observed after cardiac MRTF deletion.
Together, our results show that loss of MRTF-A and MRTF-B in
cardiomyocytes results in defects in cardiac contractility and heart
failure and point to the MRTF/SRF pathway as a potential mediator
of cardiomyopathy in humans. Numerous human mutations
causing cardiomyopathy have been identiﬁed in components of
the sarcomere and nuclear matrix that inﬂuence actin dynamics,
conﬁrming that these pathways play critical roles in the devel-
opment of heart failure (McNally and Dellefave, 2009; Morita et al.,
2010). Of particular interest is the discovery that caspase-3 clea-
vage of SRF in failing human hearts yields a dominant negative SRF
protein that blocks SRF-dependent gene expression (Chang et al.,
2003). Such a dominant negative SRF mutant would be expected
to evoke a phenotype similar to that of MRTFcdKO mice, resulting in
a loss of SRF activity. Given the pivotal role of MRTFs in modulating
gene expression in response to actin signaling and cytoskeletal
dynamics, it is reasonable to speculate that perturbation of MRTF
activity in response to such mutations may contribute to patho-
logical changes in gene expression associated with these disorders.
In the future, it will be of interest to investigate whether phar-
macologic or genetic stimulation of MRTF activity provides beneﬁt
in settings of sarcomere dysfunction and heart failure.Acknowledgments
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